About Prenuvo
Prenuvo is a company based in San Francisco (United States) founded in 2018 by Andrew Lacy. Prenuvo has raised $274.96 million across 4 funding rounds from investors including Forerunner Ventures, Left Lane Capital and Felicis Ventures. Prenuvo offers products and services including Whole Body Scan, Torso Scan, and Head and Torso Scan. Prenuvo operates in a competitive market with competitors including International SOS, IXICO, Deeptek, Subtle Medical and Invicro, among others.
- Headquarter San Francisco, United States
- Founders Andrew Lacy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Prenuvo, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$274.96 M (USD)
in 4 rounds
-
Latest Funding Round
$120 M (USD), Series C
Feb 14, 2025
-
Investors
Forerunner Ventures
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prenuvo
Prenuvo offers a comprehensive portfolio of products and services, including Whole Body Scan, Torso Scan, and Head and Torso Scan.
Comprehensive scan for early detection of tumors and disorders.
Focused scan for chest, abdomen, and pelvis health checks.
Scan assessing head, neck, and torso for potential issues.
People of Prenuvo
Unlock access to complete
Funding Insights of Prenuvo
Prenuvo has successfully raised a total of $274.96M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $120 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Prenuvo
Prenuvo has secured backing from 10 investors, including venture fund and angel investors. Prominent investors backing the company include Forerunner Ventures, Left Lane Capital and Felicis Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are directed toward tech startups by Forerunner Ventures.
|
Locked | Locked | Locked | |
|
Investments are directed toward high-growth consumer and internet technology companies.
|
Locked | Locked | Locked | |
|
Investments in technology startups are made by Felicis Ventures.
|
Locked | Locked | Locked |
Investor details for Prenuvo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prenuvo
Investment portfolio details for Prenuvo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prenuvo
Detailed financials for Prenuvo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prenuvo Comparisons
Peer comparison for Prenuvo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prenuvo
Prenuvo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as International SOS, IXICO, Deeptek, Subtle Medical and Invicro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a digital for protecting global workforces from health and security threats
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
|
| Locked | Locked | Locked |
AI-augmented diagnostic tools for radiology imaging are developed.
|
|
| Locked | Locked | Locked |
AI-driven solutions for medical diagnostic imaging are developed.
|
|
| Locked | Locked | Locked |
Provide contract research imaging services and software
|
|
| Locked | Locked | Locked |
Atherosclerotic plaque is quantified by AI using coronary CT angiograms.
|
Detailed competitors of Prenuvo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prenuvo
Complete news archive for Prenuvo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prenuvo
Prenuvo was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Prenuvo is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Andrew Lacy is the current CEO of Prenuvo. They have also founded this company.
Prenuvo is a funded company, having raised a total of $274.96M across 4 funding rounds to date.
Prenuvo was founded in 2018 and is headquartered in San Francisco, United States. MRI scans and other screening services are offered in the healthcare sector, with capabilities to identify solid tumors at Stage 1 and more than 500 health conditions. Operations focus on patient convenience through spacious facilities that support relaxation during procedures, contributing to improved health outcomes.
Prenuvo's top competitors include International SOS, Deeptek and Subtle Medical.
Prenuvo offers Whole Body Scan, Torso Scan, and Head and Torso Scan.
Prenuvo has 10 investors. Key investors include Forerunner Ventures, Left Lane Capital, Felicis Ventures, Tony Fadell, and Timothy A. Springer.